BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin
542 results:

  • 1. Giant Renal Angiomyolipomas and Pulmonary Lymphangioleiomyomatosis: Follow-up Report after More than a Decade.
    Nasir K; Ahmad A
    Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):671-675. PubMed ID: 38725217
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa.
    Tsukita H; Koyama K; Ishinari T; Takahashi A; Miyabe K; Umakoshi M; Yoshida M; Kudo-Asabe Y; Nishida A; Otsuka N; Yasui O; Kato I; Fukushima N; Goto A
    Diagn Pathol; 2024 Apr; 19(1):59. PubMed ID: 38622713
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathologic and Molecular Characterization of Xanthomatous Giant Cell Renal Cell Carcinomas: Further Support for a Close Morphologic Spectrum to Eosinophilic Solid and Cystic Renal Cell Carcinomas.
    Xu Y; Zhang X; Xia Q; Zhou Y; Wang X; Fang R; Wang Y; Tong Q; Chen J; Shi J; Fu Y; Rao Q
    Am J Surg Pathol; 2024 Jun; 48(6):662-670. PubMed ID: 38595297
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
    Johnson J; Somerfield W; Johnson SR
    Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with tsc.
    Kluiving MW; Peeters EFHI; Lely TA; van Oorschot N; de Ranitz-Greven WL
    BMC Nephrol; 2024 Mar; 25(1):113. PubMed ID: 38519911
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nutritional status as a predictive factor for paediatric tuberous sclerosis complex-associated kidney angiomyolipomas: a retrospective analysis.
    Limavady A; Marlais M
    Eur J Pediatr; 2024 Jun; 183(6):2563-2570. PubMed ID: 38483608
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.
    Alghamdi M; Chen JF; Jungbluth A; Koutzaki S; Palmer MB; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Mod Pathol; 2024 May; 37(5):100467. PubMed ID: 38460672
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Patients' and physicians' awareness of clinical symptoms and disease severity in tuberous sclerosis complex.
    Sauter M; Weber L; Jung D; Weremko M; Bachmann D; Fischereder M; Bachmann HS
    Orphanet J Rare Dis; 2024 Mar; 19(1):106. PubMed ID: 38459571
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis.
    Rosellini M; Mollica V; Marchetti A; Coluccelli S; Giunchi F; Tassinari E; Ricci C; Fiorentino M; Tallini G; De Biase D; Massari F
    Pathol Res Pract; 2024 Feb; 254():155142. PubMed ID: 38277752
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The association between computed tomography attenuation value of renal angiomyolipoma associated with tuberous sclerosis complex and response to everolimus.
    Liao Z; Li J; Zhao Y; Wang Z; Wang X; Qiu D; Zhang Y
    World J Urol; 2024 Jan; 42(1):10. PubMed ID: 38183428
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cerebral vascular and blood brain-barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex.
    Guo D; Zhang B; Han L; Rensing NR; Wong M
    Epilepsia; 2024 Feb; 65(2):483-496. PubMed ID: 38049961
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice.
    Cockerell I; Christensen J; Hoei-Hansen CE; Holst L; Grenaa Frederiksen M; Issa-Epe AI; Nedregaard B; Solhoff R; Heimdal K; Johannessen Landmark C; Lund C; Nærland T
    Orphanet J Rare Dis; 2023 Dec; 18(1):377. PubMed ID: 38042867
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pathology of hereditary renal cell carcinoma syndromes: Tuberous sclerosis complex (tsc).
    Machacek ME; Wu CL; Cornejo KM
    Semin Diagn Pathol; 2024 Jan; 41(1):8-19. PubMed ID: 37993384
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma.
    Pei J; Zhang J; Cong Q
    FEBS Open Bio; 2024 Jan; 14(1):112-126. PubMed ID: 37964489
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Genetic diffuse cystic lung disease in adults].
    Diesler R; Ahmad K; Chalabreysse L; Glérant JC; Harzallah I; Touraine R; Si-Mohamed S; Cottin V
    Rev Mal Respir; 2024 Jan; 41(1):69-88. PubMed ID: 37951745
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Renal Cell Carcinoma Associated With tsc/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up.
    Shah RB; Mehra R
    Adv Anat Pathol; 2024 Mar; 31(2):105-117. PubMed ID: 37899532
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of a Novel tsc2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations.
    Papageorgiou G; Skouteris N; Valavanis C; Stanc GM; Souka E; Charalampakis N
    Rev Recent Clin Trials; 2023; 18(4):304-312. PubMed ID: 37877150
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.
    Ricci C; Ambrosi F; Franceschini T; Giunchi F; Grillini A; Franchini E; Grillini M; Schiavina R; Massari F; Mollica V; Tateo V; Bianchi FM; Bianchi L; Droghetti M; Maloberti T; Tallini G; Colecchia M; Acosta AM; Lobo J; Trpkov K; Fiorentino M; de Biase D
    Virchows Arch; 2023 Nov; 483(5):687-698. PubMed ID: 37845471
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.
    Gau SY; Chen SL; Chang CS; Tsao TF; Tsai JD
    Int J Med Sci; 2023; 20(10):1358-1362. PubMed ID: 37786437
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 28.